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ABSTRACT
Introduction: Tuberculosis (TB) treatment failure is one of the major problems of the health sector in developing coun-
tries. Poor treatment of patients leads to drug resistance, relapse, death, and ultimately prevents TB control programs. 
This study was conducted to determine the factors affecting tuberculosis treatment failure in Khorasan and Sistan- Balo-
chistan regions which have a high prevalence of TB.
Methods: In this case - control study 270 patients with tuberculosis (90 cases, 180 controls) were analyzed. New TB 
patients registered with failure to treatment according to the national protocol between March 2008 - March 2012 were 
chosen as cases and new TB patients with negative sputum smear in the same time frame were enrolled as control 
group. Demographic data and clinical treatment outcomes were collected through interviews and file records. Multivari-
ate logistic regression analysis was used to determine the predictors of treatment failure in SPSS 19.
Results: Independent factors and predictors of failure treatment included illiteracy, a three plus positive sputum smear, 
positive sputum smear at end of the second month, non-implementation of the Directly Observed Treatment Short 
strategy by healthcare staff, history of addiction and history of diabetes.
Conclusion: Intervention programs for early detection and control of diabetes, drug control programs, giving priority to 
providing DOTS by health care workers, more individual care and attention to patients with initial smear p + 3 or those 
that remain sputum positive at the end of the second month or those who are less educated is necessary. J Microbiol 
Infect Dis 2016;6(4): 172-178
Key words: Tuberculosis, Treatment failure, Iran.
INTRODUCTION
Nearly one third of the world population (about 2 
billion people) is contaminated with Mycobacterium 
tuberculosis or is threatened by it. Each year ap-
proximately 9 million people are infected with My-
cobacterium and about 1.5 million people die as a 
result of this infectious disease. Pulmonary tuber-
culosis (TB) forms 66% of TB infections and it is 
often associated with positive sputum smear (spu-
tum containing AFB) among the adults, which in 
this case it becomes highly contagious. With the 
ascending spread of TB, in 1991, the World Health 
Organization (WHO) announced TB as a global 
emergency and announced that the immediate re-
duction of TB prevalence, the mortality caused by it 
and consequently its incidence as one of its general 
goals to be followed by all countries. The WHO also 
determined short term goals such as achieving a 
70% patient detection and 85% treatment success 
for the world states by 2000, and implementing the 
Directly Observed Treatment Short (DOTS) strategy 
into the healthcare system in order to control and 
reach its goals partially [1].
Poor treatment of TB patients would certainly 
lead to the risk of drug resistance, failure of treat-
ment, relapse, death, continuous existence of infec-
tion, and finally could abate successful implementa-
tion of TB control programs. In general, countries 
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which implement DOTS program in order to ensure 
patient treatment show increased treatment suc-
cess and less treatment absence. Hence, patient’s 
regular use of drugs must be guaranteed by imple-
menting DOTS [2].
IV drug abusers, individuals who work or live 
at places where contaminated people are concen-
trated (such as prisons and homeless shelters), and 
poor people with no access to proper medical care 
are at risk of getting TB. Compared with nonsmok-
ers, smokers are nearly more than twice as likely at 
risk of getting TB. Other diseases, such as alcohol-
ism and diabetes mellitus, can increase the risk of 
TB by three times. Studies have revealed a signifi-
cant increased treatment failure in diabetic TB pa-
tients compared with non-diabetic ones [2-4].
In recent years, the number of treatment fail-
ures has been above the average level in Khorasan-
e-Razavi Province. However, apparently no study 
has been conducted about the factors associated 
with treatment failure so far in this region. In this 
study, the researchers have investigated variables 
which have not been previously investigated in the 
province even in the previously conducted descrip-
tive studies. This study has taken into account the 
effects of occupation, place of residence, imprison-
ment, addiction and education in treatment failure. 
The current study delves into the factors associated 
with treatment failure among smear positive pa-
tients in Khorasan-e Razavi and Sistan-Baluchistan 
Provinces in Iran. 
MATERIALS AND METHODS
The study population included two provinces with 
a high incidence of tuberculosis in Iran. Khorasan-
e-Razavi with a population over 5,990,000 as well 
as 118,854 square kilometers of area is among the 
biggest provinces of Iran. This study included all 22 
cities covered by Mashhad University of Medical 
Sciences including 19 sputum smear labs and 243 
healthcare centers.
The second research area included the city of 
Zahedan, in Sistan-Baluchistan Province and its 
suburbs with an area of 36,581 square kilometers 
and nearly 660,000 inhabitants. This city has 15 
healthcare centers and four sputum smear diagno-
sis labs.
The two provinces have a common border in 
the east with two countries with a high incidence of 
TB, i.e. Afghanistan and Pakistan. The smear posi-
tive cases registered in the database were recruited 
based on definitions given in national instructions.
According to the definitions, a smear positive 
pulmonary TB patient is one that has at least two 
AFB smear-positive sputum lab results, or a patient 
that has one positive sputum smear test in terms of 
AFB and whose chest radiographic changes con-
firm pulmonary TB. In addition, a patient that has 
only one AFB smear positive sputum as well as one 
AFB positive sputum culture. The treatment failure 
case is a pulmonary TB patient with smear posi-
tive sputum for which the direct sputum test is still 
positive after five months (or more) from the start of 
treatment or it gets positive in this time span after 
becoming negative. Also, if at any time during the 
treatment of a patient, the diagnosis of MDR-TB is 
confirmed, the result of his treatment should be reg-
istered as treatment failure [1].
In the present study, a new patient is one who 
has never received anti-TB treatment in the past or 
has used anti-TB drugs less than four weeks. 
In the present study a case is a smear posi-
tive patient whose treatment result was registered 
as “treatment failure” during March 21, 2010 until 
February19, 2012 according to national TB guide-
lines. Here, the controls were new smear positive 
patients whose result of treatment according to the 
national TB protocol was labelled as “cured” in the 
same time-span.
Cases imported from other provinces or coun-
tries, patients whose result of treatment was regis-
tered as absent, patients transferred to other prov-
inces and cases with incorrect diagnosis (cases of 
Non-tuberculosis Mycobacteria that were wrongly 
diagnosed as tuberculosis are registered as incor-
rect diagnosis in the database) were excluded from 
the total number of patients due to lack of access 
to their information. Regarding the fact that in this 
study one of the variables under investigation was 
DOTS and no DOTS was conducted for patients 
with smear negative pulmonary TB in the health-
care system; therefore smear negative patients and 
cases of smear negative treatment failure were ex-
cluded from the study as well.
In this study, all new smear positive pulmo-
nary TB patients of Khorasan-e- Razavi province 
and Zahedan city and its suburbs during March 
21, 2010 until February 19, 2012 were extracted 
from the relevant TB database. Cases and controls 
were selected randomly from these patients. Then, 
information was collected through file records and 
interviews. The interviewers were given face to face 
training for correct data collection. In all the cities, 
interviews were conducted in company of autho-
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rized personnel of the relevant healthcare center of 
the urban or rural area to ensure patient coopera-
tion. Moreover, in different stages of data collection, 
patients were assured about the confidentiality of 
their personal information.
Based on a research by Viswanathan et al [4], 
the prevalence of treatment failure in diabetic pa-
tients with positive smear was 0.188 and in controls 
(smear positive non-diabetic patients) was 0.0256. 
Therefore, with the power of 90% and first type error 
equal to 5% at least 71 cases in each group for this 
case control study were calculated [5]. In the pres-
ent study, 90 cases and for each case two controls 
(180 controls) and totally 270 new smear positive 
patients were enrolled and the power increased up 
to 97%. 
Data analysis was performed by SPSS 19. Pri-
marily t-test and chi-sqaure tests were performed. 
Then, univariate and multivariate backward logistic 
regression was performed.
RESULTS
From the 270 patients (90 cases and 180 controls), 
information about 82 cases and 169 controls were 
collected correctly and completely. The address of 
8 cases and 11 controls was not found, and their 
information was not complete, therefore they were 
excluded from our study. Eventually, the information 
of 251 patients was included into the research. 
The demographics of the two groups could be 
seen in Table 1.
Table 1. Demographic characteristics of the cases and controls, in two provinces
Qualitative variables Khorasan-e-Razavi Sistan-Baluchistan Total Patients
Controls:n (%) Cases: n (%) p-value Controls:n(%) Cases: n (%) p-value Controls:n (%) Cases: n(%) p-value
Sex (M) 73/123 (59.3) 27/60 (45) 0.067 34/46 (73.9) 12/22 (54.5) 0.116 107/169 (63.3) 39/82 (47.6) 0.018
Nationality (Iranian) 103/123 (83.7) 43/60 (71.7) 0.056 29/46 (63) 18/22 (81.8) 0.115 132/169 (78.1) 61/82 (74.4) 0.512
Rural Residence 21/123 (17.1) 6/60 (10) 0.257 12/46 (26.1) 1/22 (4.5) 0.035 33 /169 (19.5) 8/82 (8.5) 0.026
Prisonment history 123/123 (100) 57/60 (95) 0.012 44/46 (95.7) 19 /22 (86.4) 0.173 2 /169 (98.8) 6/82 (92.7) 0.009
Occupation
(Insured employee) 27/123 (22) 6/60 (6) 0.025 0/46 (0) 1/22 (4.5) 0.345 27/169 (16) 7/82 (8.5) 0.071
Level of education
(uneducated) 51/123 (41.5) 33/60 (55) 0.195 29/46 (63) 15/22 (68.2) 0.673 80/169 (47.3) 48/82 (58.5) 0.218
Household Monthly income
(0-3500000 Rials) 38/123 (30.9) 30/60 (50) 0.038 29/46 (63) 11/22 (50) 0.062 67/169 (39.6) 41/82 (50) 0.218
The degree of sputum
 smear positivity
(p+1patients)
27/123 (22) 6/60 (10) 0.012 21/46 (45.7) 3/22 (13.6) 0.019 48/169 (28.4) 9/82 (11) <0.001
The result of the smear at
 the end of the second
 month (Smear negativity)
94/123 (76.4) 12/60 (20) <0.001 35/46 (76.1) 3/22 (13.6) <0.001 (76.3)129 40/82 (18.3) <0.001
DOTS (Provided by
the health care staff) 95/123 (77.2) 29/60 (48.3) <0.001 35/46 (76.1) 11/22 (50) 0.054 130/169 (76.9) 40/82 (48.8) <0.001
Smoking history
(not Smoking) 108/123 (87.8) 44/60 (73.3) 0.014 40/46 (87) 15/22 (68.2) 0.065 148/169 (87.6) 59/82 (72) 0.002
Addiction history
(not Addicted) 110/123 (89.4) 41/60 (68.3) <0.001 37/46 (80.4) 15/22 (68.2) 0.264 147/169 (87) 56/82 (68.3) <0.001
History of Diabetes
(no Diabetes) 108/123 (76.4) 46/60 (20) 0.053 42/46 (91.3) 14/22 (63.6) 0.005 150/169 (88.8) 60/82 (73.2) 0.002
Quantitative variables mean ± standard deviation p-value mean ± standard deviation p-value mean ± standard deviation p-value
Age 54.4 ± 23.2 17.3 ± 49.5 0.112 22 ± 49.5 18 ± 53.5 0.646 22.9 ± 53.1 17.5 ± 50.5 0.334
Weight 12.3±53.6 11.4± 50.9 0.145 15.1±49.3 11.6± 51.7 0.514 13.2±52.5 11.4± 51.1 0.423
Delay in treatment 5.3± 2.7 2.4±9.2 0.724 0.8± 0.4 0.63±8.0 0.262 4.7± 2.1 1.9 ± 6.2 0.816
Patient’s received
DOTS (days provided by
 healthcare staff)
18.5±42 20.6±31.6 0.001 16.9±40.9 18.3±33.8 0.115 18±41.7 19.9±32.2 <0.001
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The average age and weight in the case group 
was respectively 50.6 ± 17.5 years and 51.14 ± 
11.45 kg. The same variables were respectively 
53.12±22.9 years and 52.5±13.27 kilograms in the 
control group. The differences were not significant. 
The number of days delay in treatment was not sig-
nificant either, but the number of days the patient’s 
received DOTS by the healthcare staff was signifi-
cantly different (p-value=0.0001). Thus, receiving 
DOTS can probably be considered as one of the 
predictors of treatment failure.
Men and urban patients had a significantly 
higher chance of treatment failure as well. There 
were no significant differences between treatment 
failure and patients’ occupation. However, treat-
ment failure was higher in p+3 patients than others. 
Positive smear at the end of the second month in 
patients was also associated with more treatment 
failure. Having a history of prison, smoking, addic-
tion and diabetes significantly increased the risk of 
treatment failure in the patients, but nationality, edu-
cation and the level of monthly income had no sig-
nificant difference in the two groups (Table 1). The 
results of multivariate logistic regression analysis 
can be seen in Table 2.
Table 2. Univariate and Multivariate Logistic Regression of factors affecting treatment failure in TB patients
Qualitative variables Crude OR(%95CI) p-value
Adjusted OR
(95%CI) p-value
Sex Men (compared to women) 1.9 (1.11-3.25) 0.018 1.52(0.8-2.89) 0.200
Nationality Afghan (compared to Iranian) 1.23 (0.66-2.27) 0.512 1.33 (0.5-3.5) 0.567
Place of Residence Urban (compared to Rural) 2.59 (1.09-6.01) 0.033 2.13 (0.69-6.5) 0.189
Prison record Prison (compared to unprisoned) 6.59 (1.3-33.42) 0.023 2.22 (0.3-16.03) 0.429
Occupation
Housewife (compared
 to Insured employee) 1.67 (0.67-4.16) 0.165 2.29 (0.7-7.47) 0.163
Worker (compared
 to Insured employee) 2.67 (1.05-6.79) 0.043 2.81 (0.85-9.28) 0.089
Level of education
Below high school diploma
(compared  to uneducated) 0.66 (0.38-1.15) 0.142 0.33 (0.14-0.76) 0.011
Academic education(compared
 to uneducated) 0.45 (0.12-1.71) 0.245 0.64 (0.08-4.73) 0.664
Household Monthly income
3500000-5200000 Rials
(compared to 0-3500000 Rials) 0.54 (0.27-1.09) 0.091 0.68 (0.26-1.82) 0.455
above 5200000 Rials(compared
 to 0-3500000 Rials ) 0.74 (0.4-1.36) 0.343 1.11 (0.43-2.87) 0.817
The degree of sputum smear positivity
p+2 patients (compared
 to Insured p+1 patients) 1.88 (0.77-4.59) 0.165 1.53 (0.48-4.89) 0.473
p+3 patients(compared
 to Insured p+1 patients) 4.19 (1.9-9.27) <0.001 2.89 (1.01-8.24) 0.047
The result of the smear at the end of second month Smear positivity (compared to Smear negativity) 14.4 (7.42-27.9) <0.001 14.33 (6.77-30.33) <0.001
DOTS
Shared with the family (compared
 to Provided by the healthcare staff) 4.16 (2.21-7.82) <0.001 4.03 (1.66-9.81) 0.002
By the patient’s family(compared
 to provided by the healthcare staff) (0.96-5.63)2.32 0.062 4.19 (1.18-14.83) 0.026
Smoking history Smoking (compared to not Smoking) 2.75 (1.41-5.34) 0.003 1.12 (0.33-3.75) 0.853
Addiction history Addiction (compared to no Addiction) 3.1 (1.63-5.92) 0.003 2.9 (1.14-7.37) 0.025
Diabetes history Diabetes (compared to no Diabetes) 2.89 (1.46-5.73) 0.002 2.92 (1.11-7.67) 0.033
Quantitative variables
Age 0.99 (0.98-1.007) 0.381 0.97 (0.95-1.002) 0.071
Weight 0.99 (0.97-1.01) 0.425 1.009 (0.97-1.04) 0.582
Delay in treatment 0.99 (0.93-1.06) 0.815 1.002 (0.91-1.1) 0.963
Patient’s received DOTS (days
provided by the healthcare staff) 0.97 (0.96-0.98) <0.001 1.02(0.67-1.11) 0.511
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DISCUSSION
This case-control study shows a number of factors 
as the main risk factors in treatment failure of smear 
positive pulmonary TB patients. Despite the high in-
cidence of TB in Sistan-Baluchistan, the percentage 
of treatment failure has been lower there compared 
with Khorasan-e Razavi and the national average 
level [6].
Based on the findings of this study, independent risk 
factors and important predictors for TB treatment 
failure include level of education, the degree of spu-
tum smear positivity, the positivity of the sputum 
smear at the end of the second month, the DOTS 
implementation strategy, history of addiction, as 
well as diabetes.
The present study highlights the positive spu-
tum smear at the end of the second month as the 
strongest predictor of treatment failure. This finding 
is in line with the results of the researches conduct-
ed in southern Delhi [7], Yunnan province of China 
[8] as well as a study performed in Uganda [9].
DOTS has been implemented in many coun-
tries to ensure proper treatment of TB patients and 
has yielded effective results in increasing success 
of the treatment and reducing absence from treat-
ment [2]. Multivariate analysis in this study showed 
that DOTS given jointly by the patient’s family and 
the health care staff and the one provided only by 
the patient’s family, each increases the chance of 
treatment failure compared with DOTS presented 
only by healthcare staff. In a study by Narayanan 
et al [2], about the factors associated with failure 
and absence from treatment in southern India, the 
chance of treatment failure in patients to which 
DOTS was presented irregularly was 4.3 more than 
the chance for treatment failure in patients who had 
received complete DOTS from the healthcare sys-
tem. In another study by Jianzho et al [8], conducted 
in China, a significant difference in treatment related 
to DOTS was observed. In this study, the chance for 
treatment failure in a group on which the DOTS was 
implemented in cooperation with the patient’s family 
was 3.1 times higher than the group which DOTS 
was provided by the healthcare staff. 
The findings of the present research showed 
that uneducated people are at a higher risk of treat-
ment failure in such a way that patients with an 
educational level below high school diploma have 
less chance for treatment failure compared with the 
uneducated ones. In the present study, a small ra-
tio of patients (5.6%), were in the tertiary educated 
class and most of the patients under investigation 
in the present study belonged to the less educated 
members of the society. It is noteworthy to mention 
that approximately 75% of the patients investigated 
in the present study were either uneducated or only 
had elementary education.
In studies conducted in Uganda [9] and China 
[8], no significant difference was shown between 
patients with upper-intermediate level of education 
and the reference group (elementary and uneducat-
ed ones). However, in the Uganda study the ratio of 
educated people in the case and control groups was 
exactly the same. In a research by Narayannan et 
al [2] in southern India, the chance of treatment fail-
ure in uneducated patients was not significant com-
pared with educated patients. Also, in a research 
by Satyanarayana et al [10] in India and as well as 
in a study from Egypt [11], contrary to the results 
of the present study, there was no significant differ-
ence in treatment failure between the educated and 
uneducated patients. It is worthy to note that in all 
of these studies, education was merely categorized 
into two groups (educated vs. uneducated) while in 
our study it was categorized in three levels.
Consistent with the results of Jianzhao et al in 
China, in this study those with initial 3+ smear posi-
tivity had a higher chance of treatment failure com-
pared with others. In Jianzhao et al’s study the odds 
ratio for those with 2+ or more initial smear positivity 
compared with patients with a sputum smear below 
2+ was 2.7 (CI 95% 1.1-7.1). But Singla et al’s re-
search in southern Dehli [7] showed no significant 
difference in treatment failure in the 3+ group com-
pared with other patients.
The present work found a significant relation 
between history of addiction and treatment fail-
ure which is in line with the research conducted in 
Zabol, Iran by Adineh et al [12] in which the odds ra-
tio obtained was OR=25.61 (CI 95% 5.23-123.91).
The current study also showed a significant re-
lationship between history of diabetes and treatment 
failure. Treatment failure in diabetics was higher 
than non-diabetics which is also in line with the re-
sult of the study conducted by Shibin et al [13] in In-
dia in which the odd ratio was 2.4 (P-value=0.022).
Age was not significantly related to treatment 
failure in our study. This was in line with the studies 
carried out in Angula (in which the subjects were 
divided into two subcategories of ≤32 and >32years 
of age) [9] as well as a study by Satyanarayana et 
al [10] in India. Also in a study by Morsy et al [11] in 
Egypt, no significant relationship existed between 
treatment failures in patients under 25 years of age 
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compared with the other subgroups. Despite the dif-
ferent age-based categorization of the patients in 
the above research, none of them found a signifi-
cant relation between treatment failure and age.
Furthermore, in line with the findings of the 
present study that did not find a relation between 
treatment failure and occupation, Mosry et al [11] 
revealed no significant difference between those 
occupied with household or manual jobs compared 
with those doing other kinds of work in Egypt.
Patient’s weight was not significant in this study. In 
Dooly et al’s study [14] in Morocco weight was not 
related to treatment failure either. 
Gender was a significant variable in some stud-
ies including the one conducted by Satyanarayana 
et al [10] in India. In Satyanarayana et al’s study 
men were more prone to treatment failure. But it 
was not significant in the researches carried in 
southern Dehli [7], Egypt [11] and China [8]. In our 
study although treatment failure was higher in men, 
but this difference was not significant in multivariate 
logistic regression.
Smoking was not significant in this study and 
confirmed the results of a study by Singla et al [7] in 
southern Dehli, but Garcia et al [3] in southern Mex-
ico got different results. Garcia et al classified pa-
tients into three groups (non-smokers, light smokers 
and heavy smokers). Treatment failure was signifi-
cantly higher in light and heavy smoking groups.
Inconsistent with the findings of the study by 
Jianzhao et al in China [8], monthly income of the 
families was also not significant in our study. How-
ever, it is worth mentioning that in Jianzhao et al’s 
study the number of people with low, medium and 
high incomes were similar. But, in the current study 
almost all subjects (controls and cases) had a low 
income.
The current study had some limitations. Due 
to the few cases of patients with HIV+ (only 4 pa-
tients), this variable was excluded from our study. 
Variables such as alcohol use, chest radiography 
results, weight gain during the first two months of 
treatment, distance between the patient’s residence 
and the service center, support by family and oth-
ers, and finally the level of knowledge of family 
members and the TB patient about TB and other 
diseases like blood pressure and hepatitis were 
also among the variables excluded from this re-
search. These variables were excluded due to the 
increased study workload, time limitation and lack 
of sufficient samples. The effects of other variables 
on treatment failure are suggested to be investigat-
ed in future research.
In conclusion, intervention programs for early 
detection and control of diabetes, rehab for addicts, 
providing DOTS to patients by health care staff, 
more individual care and attention to patients with 
an initial3+ smear or cases who remain sputum 
smear positive at the end of the second month as 
well as to the less educated patients are necessary 
to successfully treat TB in Iran.
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